Skip to content
ApprovedFDA approvedStrong evidence

Selegiline

Prescription Parkinson's medicine (MAO inhibitor), also approved in the US as a patch for depression; a Hungarian development.

NootropicLongevityDopaminergicNeuroprotectionMood SupportDopamineNorepinephrine

Pharmacology

ClassDopaminergic · Neuroprotection · Mood Support
Primary targetMAO-B enzyme (irreversible inhibition)
Targets3 receptor targets
EvidenceStrong evidence
Affected systemsDopamineNorepinephrine

Contents

DETAILED OVERVIEW

What is Selegiline?

Selegiline (L-deprenyl) is a prescription medicine that the US regulator (FDA) approved for Parkinson's disease, and in its skin patch form also for depression. It is a Hungarian development: Professor József Knoll created it in the 1960s. It is prescription-only in the EU, and in Hungary a specialist's prescription is required.

It blocks an enzyme called MAO-B, which breaks down dopamine in the brain, so dopamine stays active longer where the disease has caused a shortage. Its breakdown products include amphetamine-like substances, so it can cause insomnia. At larger doses it starts to block another enzyme as well, and foods containing tyramine (a substance found in some foods) can then cause a dangerous rise in blood pressure. With antidepressants and some painkillers (such as tramadol) it should be avoided because of the risk of serotonin syndrome, and combining it with other MAO inhibitors is forbidden. It is not recommended in pregnancy and breastfeeding.

Mechanism

Selective, irreversible MAO-B

Half-life

~10 h (active metabolites longer)

Legal status

FDA + EU Rx

Receptor profile

  • MAO-B enzymeStrong
  • Dopamine reuptakeModerate
  • Neuroprotection (propargylamine)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Insomnia and disturbed sleep from the l-amphetamine/l-methamphetamine metabolites, hence morning dosing
  • Nausea, gastrointestinal upset, dry mouth
  • Orthostatic hypotension, dizziness, lightheadedness (especially at Parkinson-level doses)
  • Headache
  • Vivid dreams, less commonly hallucinations or confusion (in the elderly, at higher doses)
  • With the transdermal patch (Emsam), redness and itching at the application site

Contraindications · 6

  • Concurrent SSRIs/SNRIs/tricyclics, tramadol, meperidine, dextromethorphan: serotonin syndrome risk, avoid
  • At higher doses (>10 mg/day oral) MAO-B selectivity is lost: hypertensive crisis risk with tyramine-rich foods
  • Sympathomimetics, stimulants, ephedrine/pseudoephedrine concurrently: hypertensive reaction, do not stack
  • Must not be combined with other MAO inhibitors or linezolid
  • Not recommended in pregnancy and breastfeeding (insufficient safety data, amphetamine metabolites)
  • Only under specialist supervision; prescription-only, not suitable for self-medication

Related Nootropics

Same therapeutic category

FAQ

FAQ

Selegiline is an FDA-approved medication used mainly to treat Parkinson's disease, and in patch form also for depression. It works by blocking a specific brain enzyme that helps keep dopamine levels up in a condition where they normally decline. It is an established, medically recognized drug, not an experimental compound.

Telegram

Have a question about Selegiline?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC13H17N
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.